SE9901884D0 - Novel compounds their use and preparation - Google Patents

Novel compounds their use and preparation

Info

Publication number
SE9901884D0
SE9901884D0 SE9901884A SE9901884A SE9901884D0 SE 9901884 D0 SE9901884 D0 SE 9901884D0 SE 9901884 A SE9901884 A SE 9901884A SE 9901884 A SE9901884 A SE 9901884A SE 9901884 D0 SE9901884 D0 SE 9901884D0
Authority
SE
Sweden
Prior art keywords
ring
saturated
disorders
substituted
ring members
Prior art date
Application number
SE9901884A
Other languages
English (en)
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9901884A priority Critical patent/SE9901884D0/sv
Publication of SE9901884D0 publication Critical patent/SE9901884D0/sv
Priority to ARP000102461A priority patent/AR030022A1/es
Priority to PCT/SE2000/001017 priority patent/WO2000076984A2/en
Priority to EA200101223A priority patent/EA005820B1/ru
Priority to IL14658200A priority patent/IL146582A0/xx
Priority to MYPI20002186A priority patent/MY135666A/en
Priority to PE2000000479A priority patent/PE20010125A1/es
Priority to DE60024986T priority patent/DE60024986T2/de
Priority to KR1020017014888A priority patent/KR100722090B1/ko
Priority to EP00931877A priority patent/EP1178973B1/en
Priority to BR0010783-2A priority patent/BR0010783A/pt
Priority to AU49690/00A priority patent/AU777276C/en
Priority to CNB008102449A priority patent/CN1242995C/zh
Priority to AT00931877T priority patent/ATE313535T1/de
Priority to ES00931877T priority patent/ES2252004T3/es
Priority to JP2001503842A priority patent/JP4831903B2/ja
Priority to MXPA01011905A priority patent/MXPA01011905A/es
Priority to NZ515786A priority patent/NZ515786A/en
Priority to DK00931877T priority patent/DK1178973T3/da
Priority to CA002374898A priority patent/CA2374898C/en
Priority to US09/589,282 priority patent/US6465467B1/en
Priority to IL146582A priority patent/IL146582A/en
Priority to ZA200109571A priority patent/ZA200109571B/xx
Priority to NO20015686A priority patent/NO322220B1/no
Priority to US10/269,670 priority patent/US7534794B2/en
Priority to HK03100371.6A priority patent/HK1048311B/zh
Priority to US10/873,852 priority patent/US7071180B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE9901884A 1999-05-21 1999-05-21 Novel compounds their use and preparation SE9901884D0 (sv)

Priority Applications (27)

Application Number Priority Date Filing Date Title
SE9901884A SE9901884D0 (sv) 1999-05-21 1999-05-21 Novel compounds their use and preparation
CA002374898A CA2374898C (en) 1999-05-21 2000-05-19 Pyrazinyl-piperazine compounds, their use and preparation
CNB008102449A CN1242995C (zh) 1999-05-21 2000-05-19 化合物,它们的用途和制备方法
ES00931877T ES2252004T3 (es) 1999-05-21 2000-05-19 Nuevos compuestos, su uso y preparacion.
EA200101223A EA005820B1 (ru) 1999-05-21 2000-05-19 Агонисты и антагонисты рецепторов 5-ht
IL14658200A IL146582A0 (en) 1999-05-21 2000-05-19 Novel compounds, their use and preparation
MYPI20002186A MY135666A (en) 1999-05-21 2000-05-19 Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
PE2000000479A PE20010125A1 (es) 1999-05-21 2000-05-19 Compuestos derivados de piperazinil-pirazina que se unen al receptor 5-ht 2c
DE60024986T DE60024986T2 (de) 1999-05-21 2000-05-19 Pyrazinyl-piperazin-verbindungen, ihre anwendung und herstellung
KR1020017014888A KR100722090B1 (ko) 1999-05-21 2000-05-19 신규 화합물, 이의 용도 및 이의 제조 방법
EP00931877A EP1178973B1 (en) 1999-05-21 2000-05-19 Pyrazinyl-piperazine- compounds, their use and preparation
BR0010783-2A BR0010783A (pt) 1999-05-21 2000-05-19 Novos compostos, seu uso e preparação
AU49690/00A AU777276C (en) 1999-05-21 2000-05-19 Novel compounds, their use and preparation
ARP000102461A AR030022A1 (es) 1999-05-21 2000-05-19 Nuevos compuestos, composiciones farmaceuticas de los mismos, metodo de tratamiento, uso y preparacion de los mismos
AT00931877T ATE313535T1 (de) 1999-05-21 2000-05-19 Pyrazinyl-piperazin-verbindungen, ihre anwendung und herstellung
PCT/SE2000/001017 WO2000076984A2 (en) 1999-05-21 2000-05-19 Novel compounds, their use and preparation
JP2001503842A JP4831903B2 (ja) 1999-05-21 2000-05-19 新規化合物、その使用および製造
MXPA01011905A MXPA01011905A (es) 1999-05-21 2000-05-19 Compuestos novedosos, su uso y preparacion.
NZ515786A NZ515786A (en) 1999-05-21 2000-05-19 Aryl compounds, their preparation and use in the preparation of medicaments for the treatment of serotonin-related disorders
DK00931877T DK1178973T3 (da) 1999-05-21 2000-05-19 Pyrazinyl-piperazin-forbindelser, deres anvendelse og fremstilling
US09/589,282 US6465467B1 (en) 1999-05-21 2000-06-08 Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
IL146582A IL146582A (en) 1999-05-21 2001-11-19 A compound for the treatment of serotonin-related disease, and especially related to the HT2-5 receptor
ZA200109571A ZA200109571B (en) 1999-05-21 2001-11-20 Novel compounds, their use and preparation.
NO20015686A NO322220B1 (no) 1999-05-21 2001-11-21 Nye forbindelser, deres anvendelse og fremstilling
US10/269,670 US7534794B2 (en) 1999-05-21 2002-10-11 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
HK03100371.6A HK1048311B (zh) 1999-05-21 2003-01-15 化合物，它們的用途和製備方法
US10/873,852 US7071180B2 (en) 1999-05-21 2004-06-22 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9901884A SE9901884D0 (sv) 1999-05-21 1999-05-21 Novel compounds their use and preparation

Publications (1)

Publication Number Publication Date
SE9901884D0 true SE9901884D0 (sv) 1999-05-21

Family

ID=20415714

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9901884A SE9901884D0 (sv) 1999-05-21 1999-05-21 Novel compounds their use and preparation

Country Status (6)

Country Link
JP (1) JP4831903B2 (sv)
AR (1) AR030022A1 (sv)
MY (1) MY135666A (sv)
PE (1) PE20010125A1 (sv)
SE (1) SE9901884D0 (sv)
ZA (1) ZA200109571B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8013156B2 (en) * 2003-03-19 2011-09-06 Exelixis, Inc. Tie-2 modulators and methods of use
CL2004000826A1 (es) * 2003-04-25 2005-03-04 Pfizer Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
WO2006093014A1 (ja) * 2005-02-28 2006-09-08 Meiji Dairies Corporation ハイドロキノン長鎖誘導体及び／又はフェノキシ長鎖誘導体及びこれらを含有する医薬
US8097610B2 (en) * 2005-08-26 2012-01-17 Shionogi & Co., Ltd. Derivative having PPAR agonistic activity
JP6635999B2 (ja) * 2017-10-13 2020-01-29 株式会社ダイセル カリウム塩の製造方法、及びカリウム塩

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI193974A (sv) * 1973-07-13 1975-01-14 Merck & Co Inc
GB9420999D0 (en) * 1994-10-18 1994-12-07 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
ZA200109571B (en) 2002-11-20
MY135666A (en) 2008-06-30
JP4831903B2 (ja) 2011-12-07
JP2003502317A (ja) 2003-01-21
PE20010125A1 (es) 2001-02-06
AR030022A1 (es) 2003-08-13

Similar Documents

Publication Publication Date Title
EA200101223A1 (ru) Новые соединения, их применение и получение
AP1860A (en) Aryl fused azapolycyclic compounds.
EA200500342A1 (ru) Гетероциклические замещённые пиперазины для лечения шизофрении
FI905839A (sv) Förfarande för framställning av nya terapeutiskt användbara tricykliska kvävehaltiga föreningar
WO2005092858A3 (en) Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
SE0104332D0 (sv) Therapeutic agents
GEP20104959B (en) Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
RS20050182A (en) Derivatives of dioxane-2-alkyl carbamates,preparation method thereof and application of same in therapeutics
MY133445A (en) 2-arylethyl-(piperidin-4-ylmethyl)amine derivetives
ATE66913T1 (de) Amidverbindungen, verfahren zu ihrer herstellung und zusammensetzung zur aktivierung gastromotorischer funktionen.
BG104983A (en) Aryl fused azapolycyclic compounds
SE9901884D0 (sv) Novel compounds their use and preparation
CO4920251A1 (es) Compuestos hexahidro 1 h. -pirrolizina 7 a. -heterociclico- substituidos utiles en el control de la transmision sinaptica quimica
DE69618050D1 (de) Substituierte Benzylthienylpiperazine, ihre Anwendung als Arzneimittel und Verfahren für ihre Herstellung
ATE293591T1 (de) Neue n-(2-phenyl-3-aminopropyl)naphtamide
MXPA06000892A (es) Compuestos azapoliciclicos arilo fusionados.
EP1057829A4 (en) Condensed pyrimidine derivatives and pharmaceutical compositions containing them